Star-Shaped Amphiphilic Hyperbranched Polyglycerol Conjugated with Dendritic Poly(l-lysine) for the Codelivery of Docetaxel and MMP-9 siRNA in Cancer Therapy.
MetadataShow full item record
The drug/gene codelivery is a promising strategy for cancer treatment. Herein, to realize the codelivery of docetaxel and MMP-9 siRNA plasmid efficiently into tumor cells, a star-shaped amphiphilic copolymer consisting of hyperbranched polyglycerol derivative (HPG-C18) and dendritic poly(l-lysine) (PLLD) was synthesized by the click reaction between azido-modified HPG-C18 and propargyl focal point PLLD. The obtained HPG-C18-PLLD could form the nanocomplexes with docetaxel and MMP-9, and the complexes showed good gene delivery ability in vitro by inducing an obvious decrease in MMP-9 protein expression in MCF-7 cells. The apoptosis assay showed that the complex could induce a more significant apoptosis to breast cancer cells than that of docetaxel or MMP-9 used alone. In vivo assay indicated that the codelivery strategy displayed a better effect on tumor inhibition. Moreover, HPG-C18-PLLD displayed lower toxicity as well as better blood compatibility compared to polyethylenimine PEI-25k, which may be the result of that HPG-C18-PLLD showed the comparative MMP-9 delivery ability in vivo compared with PEI-25k even if it showed the slight lower transfection efficiency in vitro. Therefore, HPG-C18-PLLD is a safe and effective carrier for the codelivery of drug/gene, which should be encouraged in tumor therapy.
Showing items related by title, author, creator and subject.
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancerMiles, D.; Chan, Arlene; Dirix, L.; Cortés, J.; Pivot, X.; Tomczak, P.; Delozier, T.; Sohn, J.; Provencher, L.; Puglisi, F.; Harbeck, N.; Steger, G.; Schneeweiss, A.; Wardley, A.; Chlistalla, A.; Romieu, G. (2010)
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III studyBergh, J.; Bondarenko, I.; Lichinitser, M.; Liljegren, A.; Greil, R.; Voytko, N.; Makhson, A.; Cortes, J.; Lortholary, A.; Bischoff, J.; Chan, Arlene; Delaloge, S.; Huang, X.; Kern, K.; Giorgetti, C. (2012)
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancerDe Boer, R.; Kotasek, D.; White, S.; Koczwara, B.; Mainwaring, P.; Chan, Arlene; Melara, R.; Ye, Y.; Adewoye, A.; Sikorski, R.; Kaufman, P. (2012)